Corient Private Wealth LP Grows Holdings in Marsh & McLennan Companies, Inc. $MRSH

Key Points

• Corient Private Wealth increased its Marsh McLennan stake by 36.9% in the second quarter, adding 82,194 shares to own 304,876 shares valued at approximately $50.8 million. Institutional investors collectively hold 87.99% of the company.
• Marsh McLennan exceeded quarterly earnings expectations, reporting $2.96 EPS versus the $2.89 consensus and $7.28 billion in revenue, up 6.2% year over year. The company also raised its quarterly dividend to $0.99 per share, or $3.96 annually.
• Shares opened at $176.94, below the analyst consensus price target of $203.50; however, the overall analyst rating remains “Hold.” Insiders sold 19,813 shares worth about $3.6 million over the last 90 days.

Corient Private Wealth LP grew its stake in shares of Marsh & McLennan Companies, Inc. (NYSE:MRSH - Free Report) by 36.9% during the 2nd quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 304,876 shares of the financial services provider's stock after buying an additional 82,194 shares during the quarter. Corient Private Wealth LP owned 0.06% of Marsh & McLennan Companies worth $50,814,000 at the end of the most recent quarter.

Several other hedge funds and other institutional investors also recently added to or reduced their stakes in the stock. EP Wealth Advisors LLC lifted its stake in Marsh & McLennan Companies by 0.8% during the second quarter. EP Wealth Advisors LLC now owns 8,337 shares of the financial services provider's stock worth $1,823,000 after purchasing an additional 69 shares during the last quarter. Continuum Advisory LLC increased its position in shares of Marsh & McLennan Companies by 5.3% during the 1st quarter. Continuum Advisory LLC now owns 1,452 shares of the financial services provider's stock valued at $252,000 after purchasing an additional 73 shares during the last quarter. Clearstead Trust LLC raised its holdings in shares of Marsh & McLennan Companies by 12.6% during the 1st quarter. Clearstead Trust LLC now owns 668 shares of the financial services provider's stock valued at $116,000 after buying an additional 75 shares in the last quarter. Columbia Bank lifted its position in Marsh & McLennan Companies by 5.1% in the 1st quarter. Columbia Bank now owns 1,736 shares of the financial services provider's stock worth $301,000 after buying an additional 85 shares during the last quarter. Finally, Vident Advisory LLC boosted its stake in Marsh & McLennan Companies by 0.4% in the third quarter. Vident Advisory LLC now owns 20,578 shares of the financial services provider's stock worth $4,147,000 after buying an additional 90 shares in the last quarter. 87.99% of the stock is currently owned by hedge funds and other institutional investors.

Insider Buying and Selling at Marsh & McLennan Companies

In other Marsh & McLennan Companies news, SVP Paul Beswick sold 713 shares of the company's stock in a transaction that occurred on Wednesday, July 29th. The stock was sold at an average price of $198.00, for a total transaction of $141,174.00. Following the completion of the transaction, the senior vice president owned 16,376 shares of the company's stock, valued at $3,242,448. This represents a 4.17% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available at the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, insider Martin South sold 7,100 shares of Marsh & McLennan Companies stock in a transaction that occurred on Tuesday, July 28th. The stock was sold at an average price of $189.99, for a total value of $1,348,929.00. Following the completion of the sale, the insider owned 16,632 shares in the company, valued at approximately $3,159,913.68. This represents a 29.92% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Insiders sold 19,813 shares of company stock valued at $3,597,903 in the last 90 days. Insiders own 0.38% of the company's stock.

Marsh & McLennan Companies Stock Down 0.2%

NYSE:MRSH opened at $176.94 on Friday. The company has a market cap of $84.44 billion, a price-to-earnings ratio of 21.63, a P/E/G ratio of 2.46 and a beta of 0.58. The company has a quick ratio of 1.14, a current ratio of 1.14 and a debt-to-equity ratio of 1.22. The firm's fifty day moving average price is $185.83. Marsh & McLennan Companies, Inc. has a 52 week low of $156.60 and a 52 week high of $207.82.

Marsh & McLennan Companies (NYSE:MRSH - Get Free Report) last released its quarterly earnings data on Tuesday, July 21st. The financial services provider reported $2.96 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $2.89 by $0.07. The firm had revenue of $7.28 billion for the quarter. Marsh & McLennan Companies had a net margin of 14.24% and a return on equity of 32.67%. The business's revenue for the quarter was up 6.2% compared to the same quarter last year. As a group, analysts anticipate that Marsh & McLennan Companies, Inc. will post 10.44 EPS for the current year.

Marsh & McLennan Companies Increases Dividend

The firm also recently declared a quarterly dividend, which was paid on Friday, August 14th. Investors of record on Thursday, July 23rd were issued a dividend of $0.99 per share. The ex-dividend date was Thursday, July 23rd. This represents a $3.96 dividend on an annualized basis and a yield of 2.2%. This is a boost from Marsh & McLennan Companies's previous quarterly dividend of $0.90. Marsh & McLennan Companies's dividend payout ratio (DPR) is presently 48.41%.

Analysts Set New Price Targets

MRSH has been the subject of a number of recent research reports. JPMorgan Chase & Co. boosted their price objective on shares of Marsh & McLennan Companies from $206.00 to $212.00 and gave the stock an "overweight" rating in a report on Monday, July 13th. Mizuho increased their target price on shares of Marsh & McLennan Companies from $197.00 to $201.00 and gave the company a "neutral" rating in a report on Wednesday, July 22nd. Cantor Fitzgerald boosted their price target on shares of Marsh & McLennan Companies from $210.00 to $218.00 and gave the stock an "overweight" rating in a research note on Thursday, July 9th. Morgan Stanley upped their price target on shares of Marsh & McLennan Companies from $180.00 to $200.00 and gave the company an "equal weight" rating in a research report on Wednesday, August 19th. Finally, Wells Fargo & Company lifted their price objective on Marsh & McLennan Companies from $186.00 to $188.00 and gave the stock an "equal weight" rating in a report on Wednesday, July 22nd. Two analysts have rated the stock with a Strong Buy rating, five have given a Buy rating, eleven have assigned a Hold rating and one has assigned a Sell rating to the company. According to MarketBeat.com, the company has an average rating of "Hold" and a consensus price target of $203.50.

Marsh & McLennan Companies Profile

Marsh & McLennan Companies, now operating under the name Marsh McLennan, is a global professional services firm that helps organizations manage risk, strategy and people-related challenges. Its businesses serve corporations, governments, institutional investors and other organizations across a broad range of industries and geographies.

The company's principal businesses include Marsh, an insurance brokerage and risk advisory firm; Guy Carpenter, which provides reinsurance brokerage and related risk management services; Mercer, which offers consulting in areas such as talent, health, retirement and investments; and Oliver Wyman, a management consulting firm.

Want to see what other hedge funds are holding MRSH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Marsh & McLennan Companies, Inc. (NYSE:MRSH - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.